India has approved further clinical trials for its first homegrown mRNA-based COVID-19 vaccine, developed by Gennova Biopharmaceuticals, after the shot is found to be safe and effective in an early-stage study.

The country has authorised emergency use for two domestically developed COVID-19 jabs, made by Bharat Biotech and Zydus Cadila, but does not have mRNA-based vaccines yet in its immunisation programme before a potential third coronavirus wave.
https://leadership.ng/india-approves-further-trials-for-homegrown-m...